Suppr超能文献

相似文献

1
Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice.
J Lipid Res. 2010 Jun;51(6):1464-70. doi: 10.1194/jlr.M002972. Epub 2010 Jan 28.
2
Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.
Am J Pathol. 2011 Sep;179(3):1179-87. doi: 10.1016/j.ajpath.2011.05.016. Epub 2011 Jun 30.
3
Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.
Am J Nephrol. 2004 Jan-Feb;24(1):20-31. doi: 10.1159/000075362. Epub 2003 Dec 10.
5
Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.
Br J Nutr. 2016 Oct;116(8):1326-1335. doi: 10.1017/S0007114516003512. Epub 2016 Oct 11.
7
Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.
J Lipid Res. 2017 Dec;58(12):2264-2274. doi: 10.1194/jlr.M078204. Epub 2017 Sep 14.

引用本文的文献

1
Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey.
Lipids Health Dis. 2020 May 27;19(1):110. doi: 10.1186/s12944-020-01241-7.
3
Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.
Atherosclerosis. 2018 Jan;268:68-75. doi: 10.1016/j.atherosclerosis.2017.11.005. Epub 2017 Nov 10.
4
Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.
J Lipid Res. 2017 Dec;58(12):2264-2274. doi: 10.1194/jlr.M078204. Epub 2017 Sep 14.
5
Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance.
PLoS One. 2015 Apr 24;10(4):e0121555. doi: 10.1371/journal.pone.0121555. eCollection 2015.
8
Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.
Am J Pathol. 2011 Sep;179(3):1179-87. doi: 10.1016/j.ajpath.2011.05.016. Epub 2011 Jun 30.

本文引用的文献

1
Low density lipoproteins transactivate EGF receptor: role in mesangial cell proliferation.
Life Sci. 2008 Oct 24;83(17-18):595-601. doi: 10.1016/j.lfs.2008.08.010. Epub 2008 Sep 6.
2
Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway.
Kidney Int. 2008 Sep;74(5):577-84. doi: 10.1038/ki.2008.210. Epub 2008 May 28.
3
Effect of statins on the development of renal dysfunction.
Am J Cardiol. 2008 Apr 1;101(7):975-9. doi: 10.1016/j.amjcard.2007.11.042. Epub 2008 Jan 25.
4
Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
J Urol. 2008 Apr;179(4):1631-6. doi: 10.1016/j.juro.2007.11.042. Epub 2008 Mar 4.
5
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.
J Lipid Res. 2008 Mar;49(3):521-30. doi: 10.1194/jlr.M700329-JLR200. Epub 2007 Nov 21.
6
Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
Kidney Int. 2007 Aug;72(4):473-80. doi: 10.1038/sj.ki.5002366. Epub 2007 Jun 13.
7
Mouse models for atherosclerosis and pharmaceutical modifiers.
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1706-21. doi: 10.1161/ATVBAHA.107.142570. Epub 2007 May 31.
8
Statins for improving renal outcomes: a meta-analysis.
J Am Soc Nephrol. 2006 Jul;17(7):2006-16. doi: 10.1681/ASN.2006010012. Epub 2006 Jun 8.
9
Dyslipidemia and the progression of renal disease in chronic renal failure patients.
Kidney Int Suppl. 2005 Dec(99):S87-93. doi: 10.1111/j.1523-1755.2005.09916.x.
10
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.
Diabetes. 2005 Sep;54(9):2628-37. doi: 10.2337/diabetes.54.9.2628.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验